Price T Rowe Associates Inc Wave Life Sciences Ltd. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,126,604 shares of WVE stock, worth $42.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,126,604

Previous 1,439,271 117.24%

Holding current value

$42.2 Million

Previous $7.18 Million 256.94%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.12 - $9.01 $8.64 Million - $15.2 Million	1,687,333 Added 117.24%	3,126,604 $25.6 Million
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $1.85 Million - $2.73 Million	-421,983 Reduced 22.67%	1,439,271 $7.18 Million
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $827,974 - $1.6 Million	233,891 Added 14.37%	1,861,254 $11.5 Million
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $1.49 Million - $2.46 Million	358,201 Added 28.22%	1,627,363 $8.22 Million
Q3 2023 Nov 14, 2023	BUY	$3.56 - $5.75 $4.32 Million - $6.98 Million	1,213,995 Added 2200.58%	1,269,162 $7.3 Million
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $65,314 - $87,271	18,608 Added 50.9%	55,167 $201,000
Q1 2023 May 15, 2023	BUY	$3.58 - $6.3 $82,698 - $145,530	23,100 Added 171.63%	36,559 $159,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $94,194 - $207,347	-29,621 Reduced 68.76%	13,459 $94,000
Q3 2022 Nov 14, 2022	BUY	$2.37 - $4.28 $33,417 - $60,348	14,100 Added 48.65%	43,080 $156,000
Q2 2022 Aug 15, 2022	SELL	$1.23 - $3.25 $1,232 - $3,256	-1,002 Reduced 3.34%	28,980 $94,000
Q1 2022 May 16, 2022	BUY	$2.0 - $3.28 $25,600 - $41,984	12,800 Added 74.5%	29,982 $60,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $56,206 - $92,185	-17,900 Reduced 51.02%	17,182 $54,000
Q2 2021 Aug 16, 2021	BUY	$5.65 - $7.47 $27,086 - $35,811	4,794 Added 15.83%	35,082 $234,000
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $4.13 Million - $8.84 Million	-736,108 Reduced 96.05%	30,288 $170,000
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $5.36 Million - $7.1 Million	766,396 New	766,396 $6.03 Million

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Wave Life Sciences Ltd. Transaction History